• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX TPE; SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX TPE; SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA Back to Search Results
Catalog Number 107144
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypersensitivity/Allergic reaction (1907); Hyperthermia (1909); Nausea (1970); Vomiting (2144); Chills (2191)
Event Date 03/04/2020
Event Type  Injury  
Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that one hour and 45 minutes after starting therapeutic plasma exchange (tpe) treatment using a prismaflex tpe set, the patient experienced chills (37°c.) and the extracorporeal circuit was returned due to high transmembrane pressure alarm that was triggered three times.Treatment was discontinued.It was reported this was the patient's first plasmapherese tpe session (with albumin).A new prismaflex tpe set was used to continue treatment.After continuing treatment with the new set, the patient experienced chills, hyperthermia at (38.5°c), nausea and vomiting.Treatment was discontinued, and the patient was treated with paracetamol (1g) and dexchlorpheniramine (2mg).No additional information is available.
 
Manufacturer Narrative
B5: it was reported during follow up that priming with injected nacl solution was performed for approximately less than 10 minutes.H10: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX TPE
Type of Device
SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
MDR Report Key9915855
MDR Text Key188646137
Report Number8010182-2020-00025
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2021
Device Catalogue Number107144
Device Lot Number19J0501
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/10/2020
Initial Date FDA Received04/02/2020
Supplement Dates Manufacturer Received04/23/2020
Supplement Dates FDA Received04/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PRISMAFLEX CONTROL UNIT
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-